• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Stratasys Ltd. (Amendment)

    4/4/24 3:44:54 PM ET
    $SSYS
    Computer peripheral equipment
    Technology
    Get the next $SSYS alert in real time by email
    SC 13D/A 1 stratasys_ltd.4-3-24_13d.htm SC 13D/A SC 13D/A

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D/A
    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

    (Amendment No. 1)*

     

     

    Stratasys Ltd.

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    M85548101

    (CUSIP Number)

     

    Brad Nelson

    191 University Blvd, Suite 246

    Denver, Colorado 80206

    (239) 970-4085

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

    April 1, 2024

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ☐

     

    NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     


     

    1

     

     NAMES OF REPORTING PERSONS

     

    Farhad Fred Ebrahimi

     

    2

     

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

              (a) ☐

              (b) ☐

     

    3

     

     SEC USE ONLY

     

    4

     

    SOURCE OF FUNDS (See Instructions)

     

    PF

     

    5

     

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED ☐

    PURSUANT TO ITEMS 2(d) or 2(e)

     

     

    6

     

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States

     

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

     

    7

     

      SOLE VOTING POWER

     

     0 shares

     

    8

     

      SHARED VOTING POWER

     

     3,410,795 shares

     

    9

     

      SOLE DISPOSITIVE POWER

     

     0 shares

     

    10

     

      SHARED DISPOSITIVE POWER

     

    3,410,795 shares

     

    11

     

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     3,410,795 shares

     

    12

     

     CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐

     (See Instructions)

     

     

    13

     

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    4.90%

     

    14

     

      TYPE OF REPORTING PERSON (See Instructions)

     

      IN

    - 2 -

     


    1

     

     NAMES OF REPORTING PERSONS

     

    Mary Wilkie Ebrahimi

     

    2

     

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

              (a) ☐

              (b) ☐

     

    3

     

     SEC USE ONLY

     

    4

     

    SOURCE OF FUNDS (See Instructions)

     

    PF

     

    5

     

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED ☐

    PURSUANT TO ITEMS 2(d) or 2(e)

     

     

    6

     

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

     

    7

     

      SOLE VOTING POWER

     

       0 shares

     

    8

     

      SHARED VOTING POWER

     

    3,410,795 shares

     

    9

     

      SOLE DISPOSITIVE POWER

     

    0 shares

     

    10

     

      SHARED DISPOSITIVE POWER

     

       3,410,795 shares

     

    11

     

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    3,410,795 shares

     

    12

     

     CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐

     (See Instructions)

     

     

    13

     

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     4.90%

     

    14

     

      TYPE OF REPORTING PERSON (See Instructions)

     

    IN

    - 3 -

     


     

    Schedule 13D

    This Amendment No. 1 to Schedule 13D amends the Schedule 13D filed on January 26, 2024.

    ITEM 1.
    Security and Issuer.

    This statement relates to the common stock, $0.01 par value per share, of Stratasys Ltd. (the "Common Stock"), a corporation organized under the laws of Israel, with its principal executive offices at 1 Holtzman Street, Science Park, P.O. Box 2496, Rehovot, Israel 7670401.

    ITEM 2.
    Identity and Background.
    (a)
    This statement is being filed by Farhad Fred Ebrahimi and Mary Wilkie Ebrahimi (the "Reporting Persons").
    (b)
    191 University Blvd, Suite 246, Denver, Colorado 80206.
    (c)
    Farhad Fred Ebrahimi is a private investor, and Mary Wilkie Ebrahimi is not employed.
    (d)
    Neither of the Reporting Persons has, during the last five years, been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).
    (e)
    Neither of the Reporting Persons has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding become (or remain) subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities law, or finding any violation with respect to such laws.
    (f)
    United States.
    ITEM 3.
    Source and Amount of Funds or Other Consideration.

    The Reporting Persons paid $1,240,133 from personal funds to acquire the Common Stock.

    ITEM 4.
    Purpose of Transaction.

    The Reporting Persons have sold Common Stock in the open market and reduced their holdings to below 5%.

    The Reporting Persons may make additional sales or purchases of Common Stock or other securities of the Issuer, either in the open market or in private transactions, depending on their evaluation of the Issuer’s business, prospects and financial condition, the market for the Common Stock or other securities, other opportunities available to them, general economic conditions, money and stock market conditions, and other future developments.

    - 4 -

     


    Except as set forth in this document, none of the Reporting Persons has any present plans which relate to or would result in:

    (a)
    The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;
    (b)
    An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;
    (c)
    A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;
    (d)
    Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;
    (e)
    Any material change in the present capitalization or dividend policy of the Issuer;
    (f)
    Any other material change in the Issuer’s business or corporate structure;
    (g)
    Changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;
    (h)
    Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;
    (i)
    A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934; or
    (j)
    Any action similar to any of those enumerated above.

    The Reporting Persons reserve the right, subject to applicable law, to review or reconsider their position, change their purpose, take other actions (including actions that could involve one or more of the types of transactions or have one or more of the results described in (a) through (j) above, or formulate and implement plans or proposals with respect to any of the foregoing.

    ITEM 5.
    INTEREST IN SECURITIES OF THE ISSUER.
    (a)
    Farhad Fred Ebrahimi and Mary Wilkie Ebrahimi jointly hold 3,410,795 shares of the Issuer’s Common Stock. Based on the number of shares reported as outstanding in the Issuer’s 6-K, Exhibit 99.1, filed with the Securities Exchange Commission on March 7, 2024, this represents 4.90% of the outstanding Common Stock of the Issuer.
    (b)
    Number of shares as to which Farhad Fred Ebrahimi and Mary Wilkie Ebrahimi have:
    (i)
    sole power to vote or to direct the vote: 0 shares

    - 5 -

     


    (ii)
    shared power to vote or to direct the vote: 3,410,795 shares
    (iii)
    sole power to dispose or to direct the disposition of: 0 shares
    (iv)
    shared power to vote or to direct the vote: 3,410,795 shares
    (c)
    The following transactions have been effected by the Reporting Persons in the last 60 days or since their last 13D:

    Date of Transaction

    Type of Transaction

    Quantity

    Weighted Average Price per Share (in US Dollars)

    2/21/2024

    Purchase of Common Stock

    100

    $14.90

    3/06/2024

    Purchase of Common Stock

    73,500

    $14.90

    3/20/2024

    Sale of Common Stock

    120,666

    $11.64

    3/26/2024

    Purchase of Common Stock

    7,900

    $18.16

    4/01/2024

    Sale of Common Stock

    100,000

    $11.54

     

     

     

    All of these transactions were effected by the Reporting Persons through Fidelity Investments’ online brokerage.

     

    (d)
    No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of the shares beneficially owned by any of the Reporting Persons.
    (e)
    Not applicable
    ITEM 6.
    Contracts, Arrangements, Understandings or RelationSHips with Respect to Securities of the Issuer.

    The following PUT options are outstanding that may be exercised by the purchasers. The obligations to buy are subject to conditions which have not occurred and are beyond the Reporting Persons’ control.

    Expiration Date

    Type of Transaction

    Quantity

          Strike Price

    1/17/2025

    Obligation to buy

             200

    $15.00

    1/17/2025

    Obligation to buy

     410,800

    $17.50

     

     

    - 6 -

     


    ITEM 7.
    Material to Be Filed as Exhibits.

    Exhibit A - Power of Attorney

    Exhibit B - Power of Attorney

    Exhibit C - Agreement regarding filing of joint Schedule 13D.

     

    - 7 -

     


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: April 3, 2024

    By: *
    Name: Farhad Fred Ebrahimi

    By:
    **
    Name: Mary Wilkie Ebrahimi

    *By /s/ Brad Nelson
    Brad Nelson as Attorney-in-Fact


    **By:
    /s/ Brad Nelson
    Brad Nelson as Attorney-in-Fact

     

    *This Schedule 13D/A was executed by Brad Nelson pursuant to a Power of Attorney filed herewith as Exhibit A.

     

    **This Schedule 13D/A was executed by Brad Nelson pursuant to a Power of Attorney filed herewith as Exhibit B.

     

    - 8 -

     


    EXHIBIT INDEX

     

    Exhibit A - Power of Attorney

    Exhibit B - Power of Attorney

    Exhibit C - Agreement regarding filing of joint Schedule 13D

     

    Exhibit A - POWER OF ATTORNEY

     

    KNOW ALL BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Brad Nelson his true and lawful attorney-in-fact and agent, for him and in his name, place and stead, in any and all capacities (including, but not limited to, as a general partner of any partnership, a member or manager of any limited liability company, a trustee of any trust, or an officer or director of any corporation or other entity), with full power of substitution, to: (i) sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed pursuant to Section 13 or 16 of the Securities Exchange Act of 1934, as amended, and any and all regulations promulgated thereunder, (ii) sign any notice on Form 144 (including any amendments thereto) pursuant to Rule 144 of the Securities Act of 1933, as amended, (iii) file the same (including any amendments thereto), with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and any stock exchange or similar authority, and (iv) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this power of attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing necessary, desirable or appropriate.

    The understood hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney.

    This power of attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the attorney-in-fact.

    IN WITNESS WHEREOF, the undersigned has executed this power of attorney as of the 11th day of February, 2014.

     

    /s/ Farhad Fred Ebrahimi

    --------------------------

    Farhad Fred Ebrahimi

     

    - 9 -

     


    Exhibit B - POWER OF ATTORNEY

     

    KNOW ALL BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Brad Nelson her true and lawful attorney-in-fact and agent, for her and in her name, place and stead, in any and all capacities (including, but not limited to, as a general partner of any partnership, a member or manager of any limited liability company, a trustee of any trust, or an officer or director of any corporation or other entity), with full power of substitution, to: (i) sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed pursuant to Section 13 or 16 of the Securities Exchange Act of 1934, as amended, and any and all regulations promulgated thereunder, (ii) sign any notice on Form 144 (including any amendments thereto) pursuant to Rule 144 of the Securities Act of 1933, as amended, (iii) file the same (including any amendments thereto), with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and any stock exchange or similar authority, and (iv) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this power of attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing necessary, desirable or appropriate.

    The understood hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney.

    This power of attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the attorney-in-fact.

    IN WITNESS WHEREOF, the undersigned has executed this power of attorney as of the 11th day of February, 2014.

     

    /s/ Mary Wilkie Ebrahimi

    ---------------------------

    Mary Wilkie Ebrahimi

     

    - 10 -

     


     

    Exhibit C - AGREEMENT

     

    Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Stratasys Ltd.

    Executed as a sealed instrument this 25th day of January, 2024.

     

    By: ***

    ----------------------------------------

    Name: Farhad Fred Ebrahimi

     

    By: ****

    ----------------------------------------

    Name: Mary Wilkie Ebrahimi

     

    ***By: /s/ Brad Nelson

    ------------------------

    Brad Nelson as Attorney-in-Fact

     

    ****By: /s/ Brad Nelson

    ------------------------

    Brad Nelson as Attorney-in-Fact

     

    *** This Schedule was executed by Brad Nelson pursuant to a Power of Attorney, filed with the Securities and Exchange Commission herewith.

     

    **** This Schedule was executed by Brad Nelson pursuant to a Power of Attorney, filed with the Securities and Exchange Commission herewith.

    - 11 -

     


    Get the next $SSYS alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SSYS

    DatePrice TargetRatingAnalyst
    2/13/2024$24.00Overweight
    Cantor Fitzgerald
    1/4/2023$15.00Hold → Buy
    Needham
    11/8/2022Underperform → Mkt Perform
    William Blair
    8/17/2022$24.00Outperform
    Credit Suisse
    5/17/2022$25.00 → $23.00Underweight → Neutral
    JP Morgan
    2/24/2022$30.00Hold → Buy
    Cross Research
    11/4/2021Neutral → Underweight
    JP Morgan
    11/4/2021Overweight → Neutral
    JP Morgan
    More analyst ratings

    $SSYS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Stratasys Celebrates 10 Years of the Fortus 450mc 3D Printer With Launch of Factory-Floor-Ready Additive Manufacturing Solution

      New model builds on proven success with upgraded features for advanced manufacturing applications Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of the newest version of its Fortus® 450mc 3D printer, marking the 10th anniversary of one of the industry's most trusted manufacturing solutions. Over the past decade, the Fortus 450mc system has earned its reputation as a reliable, mid-level FDM® workhorse, with 92% of installed systems still producing parts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709341667/en/The Stratasys Fortus 450mc is a workhorse industrial 3D printer, with more than 92 percent of them insta

      7/9/25 8:15:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys Launches North American Tooling Center of Excellence with Automation Intelligence, LLC to Deliver Real-World Additive Manufacturing Value

      New Center of Excellence to serve as a catalyst for global expansion of advanced additive tooling solutions for automotive and industrial manufacturers Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of the North American Stratasys Tooling Center (NASTC), a new collaboration with Automation Intelligence, LLC (AI), at AI's manufacturing site in Flint, Michigan. This dedicated tooling hub is designed to assist manufacturers validate and scale practical applications for additive manufacturing in production environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611034678/en/Robotic arm that is being used in the ne

      6/11/25 8:15:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys Releases First Quarter 2025 Financial Results

      Revenue of $136.0 million, compared to $144.1 million in the prior year period GAAP net loss of $13.1 million, or $0.18 per diluted share, and non-GAAP net income of $2.9 million, or $0.04 per diluted share Adjusted EBITDA of $8.2 million, compared to $4.1 million in the prior year period $150.1 million cash, equivalents and short-term deposits and no debt at March 31, 2025 Adds $120 million in cash from investment by Fortissimo Capital subsequent to quarter end Raises 2025 Outlook Stratasys Ltd. (NASDAQ:SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the first quarter ended March 31, 2025. Dr. Yoav Zeif, Stratasys' Chief Executive O

      5/8/25 7:00:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology

    $SSYS
    SEC Filings

    See more
    • SEC Form SD filed by Stratasys Ltd.

      SD - STRATASYS LTD. (0001517396) (Filer)

      5/29/25 6:17:50 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • SEC Form 6-K filed by Stratasys Ltd.

      6-K - STRATASYS LTD. (0001517396) (Filer)

      5/8/25 1:05:58 PM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • SEC Form 6-K filed by Stratasys Ltd.

      6-K - STRATASYS LTD. (0001517396) (Filer)

      5/8/25 7:19:10 AM ET
      $SSYS
      Computer peripheral equipment
      Technology

    $SSYS
    Leadership Updates

    Live Leadership Updates

    See more
    • Stratasys Closes $120 Million Strategic Investment by Fortissimo Capital

      Further bolsters strong balance sheet Positions company for future growth through strategic investments to further enhance industry leadership Appoints Yuval Cohen to Board of Directors Stratasys Ltd. (NASDAQ:SSYS) ("the Company"), a leader in polymer 3D printing solutions, today announced the closing of a $120 million strategic investment by Fortissimo Capital ("Fortissimo"), a leading Israeli private equity fund investing in technology and industrials. As part of the closing of the investment, Fortissimo has acquired approximately 14% of Stratasys' issued and outstanding ordinary shares through a direct purchase of 11,650,485 newly issued ordinary shares at $10.30 per share. As a resul

      4/10/25 4:30:00 PM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys Announces $120 Million Equity Investment from Fortissimo Capital

      Transaction at a Premium Underscores Leading Position in the Additive Manufacturing Industry and Positions Stratasys to Drive Growth Strengthens Balance Sheet to Capture Market Opportunities Fortissimo's Founding and Managing Partner, Yuval Cohen, to Join the Stratasys Board Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that Fortissimo Capital ("Fortissimo"), a leading Israeli private equity fund investing in technology and industrials, has entered into an agreement to invest $120 million in the Company, acquiring approximately 14% of Stratasys' issued and outstanding ordinary shares through a direct purchase of

      2/2/25 11:09:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys Publishes Third ESG and Sustainability Report; Advances Leadership in Sustainable Additive Manufacturing

      Stratasys highlights achievements in environmental, social, and governance initiatives, cementing its position as a supplier of choice for sustainable AM-enabled production solutions. Stratasys Ltd. (NASDAQ:SSYS) today announced the publication of its third Mindful Manufacturing™ ESG (Environment, Social, and Governance) and Sustainability Report. Prepared in accordance with the Global Reporting Initiative (GRI) and referencing SASB (Sustainability Accounting Standards Board) standards, the report underscores Stratasys' commitment to ESG excellence and enterprise risk management through best-in-class corporate governance, a people-first approach, meaningful social impact, and robust envir

      12/18/24 8:15:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology

    $SSYS
    Financials

    Live finance-specific insights

    See more
    • Stratasys Releases First Quarter 2025 Financial Results

      Revenue of $136.0 million, compared to $144.1 million in the prior year period GAAP net loss of $13.1 million, or $0.18 per diluted share, and non-GAAP net income of $2.9 million, or $0.04 per diluted share Adjusted EBITDA of $8.2 million, compared to $4.1 million in the prior year period $150.1 million cash, equivalents and short-term deposits and no debt at March 31, 2025 Adds $120 million in cash from investment by Fortissimo Capital subsequent to quarter end Raises 2025 Outlook Stratasys Ltd. (NASDAQ:SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the first quarter ended March 31, 2025. Dr. Yoav Zeif, Stratasys' Chief Executive O

      5/8/25 7:00:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys Conference Call to Discuss First Quarter 2025 Financial Results

      Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025. The Company plans to hold the conference call to discuss its first quarter 2025 financial results on Thursday, May 8, 2025, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=pGlPRdRX To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior

      4/24/25 7:00:00 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

      CollPlant announces six-month study data from its regenerative breast implant program, which could provide a revolutionary alternative to women for aesthetic or medical purposes and aims to address a $3 billion market opportunity Recently received a $2 million development payment from AbbVie Conference call to be held today at 10:00 a.m. U.S. EDT REHOVOT, Israel, March 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced its 2024 financial results and provided a corp

      3/26/25 8:00:00 AM ET
      $CLGN
      $SSYS
      Industrial Specialties
      Health Care
      Computer peripheral equipment
      Technology

    $SSYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

      SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

      11/14/24 6:18:58 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

      SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

      11/13/24 4:30:24 PM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

      SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

      11/5/24 5:11:59 PM ET
      $SSYS
      Computer peripheral equipment
      Technology

    $SSYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald initiated coverage on Stratasys with a new price target

      Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00

      2/13/24 6:45:02 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys upgraded by Needham with a new price target

      Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00

      1/4/23 7:56:13 AM ET
      $SSYS
      Computer peripheral equipment
      Technology
    • Stratasys upgraded by William Blair

      William Blair upgraded Stratasys from Underperform to Mkt Perform

      11/8/22 7:27:14 AM ET
      $SSYS
      Computer peripheral equipment
      Technology